SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008649
Filing Date
2023-05-09
Accepted
2023-05-09 07:01:23
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230331x10q.htm   iXBRL 10-Q 1514482
2 EX-31.1 tmb-20230331xex31d1.htm EX-31.1 7123
3 EX-31.2 tmb-20230331xex31d2.htm EX-31.2 7113
4 EX-32.1 tmb-20230331xex32d1.htm EX-32.1 9198
5 GRAPHIC tmb-20230331x10q001.jpg GRAPHIC 17235
  Complete submission text file 0001558370-23-008649.txt   5430279

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20230331.xsd EX-101.SCH 35034
7 EX-101.CAL tmb-20230331_cal.xml EX-101.CAL 33074
8 EX-101.DEF tmb-20230331_def.xml EX-101.DEF 116900
9 EX-101.LAB tmb-20230331_lab.xml EX-101.LAB 288665
10 EX-101.PRE tmb-20230331_pre.xml EX-101.PRE 214605
50 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230331x10q_htm.xml XML 969994
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 23899892
SIC: 2834 Pharmaceutical Preparations